Enhancing effect of chemically conjugated deoxycholic acid on permeability of calcitonin in Caco-2 cells

Drug Development Research

Volumn 64, Issue 2, 2005, Pages 129-135

  Kim, Sunhee ^a   Lee, Hyunhee ^a   Lee, Seulki ^a   Kim, Sang Kyoon ^a   Lee, Yong Kyu ^a   Chung, Bong Hyun ^b   Moon, Hyun Tae ^c   Byun, Youngro ^a  

^a Gwangju Institute of Science and Technology (GIST)   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Mediplex Corporation   (South Korea)

Author keywords

Calcitonin; Chemical conjugate; Deoxycholic acid; DMSO; Oral delivery

Indexed keywords

BILE ACID; CALCITONIN; CYCLIC AMP; DEOXYCHOLIC ACID; DIMETHYL SULFOXIDE; SALCATONIN;

ARTICLE; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; CHEMICAL MODIFICATION; CIRCULAR DICHROISM; DOSE RESPONSE; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

EID: 19944366963     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10423     Document Type: Article

References (21)

1. Artursson P. 1990. Epithelial transport of drugs in cell culture I: a model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J Pharm Sci 79:476-482.
2. Banga AK, Chien YW, 1988. Systemic delivery of therapeutic peptides and proteins. Int J Pharmacol 48:15-50.
3. Buclin T, Cosma RM, Burckhardt P, Azria M, Attinger M. 2002. Bioavailability and biological efficacy of a new oral formulation of salmon calcitonin in healthy volunteers. J Bone Miner Res 17:1478-1485.
4. Conradi RA, Hilgers AR, Burton PS, 1990. Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm Res 7:902-910.
5. Danilson H, Sjovall J. 1985. Steroids and bile acids. Elsevier, Amsterdam.
6. Dogru ST, Calis S, Oner F. 2000. Oral multiple w/o/w emulsion formulation of a peptide salmon calcitonin: in vitro-in vivo evaluation. J Clin Pharm Ther 25:435-443.
7. Epand RM, Epand RF, Orlowski RC. 1985. Presence of an amphiphatic helical segment and its relationship to biological potency of calcitonin analogs. Int J Pept Protein Res 25:105-111.
8. Findlay DM, Michelangeli VP, Martin TJ, Orlowski RC, Seyler JK. 1985. Conformational requirements for activity of salmon calcitonin. Endocrinology 117:801-804.
9. Kleerekoper M, Schein JR. 2001. Comparative safety of bone remodeling agents with a focus on osteoporosis therapies. J Clin Pharmacol 41:239-250.
10. Komarova SV, Shum JB, Paige LA, Sims SM, Dixon SJ. 2003. Regulation of osteoclasts by calcitonin and amphiphilic calcitonin conjugates: role of cytosolic calcium. Calcif Tissue Int 73:265-273.
11. Kramer W, Wess G, Neckermann G, et al. 1994. Intestinal absorption of peptides by coupling to bile acids. J Biol Chem 269:10621-10627.
12. Lee YK, Kim SH, Byun YR. 2000. Oral delivery of new heparin derivatives in rats. Pharm Res 17:1259-1264.
13. Lee YK, Nam JH, Shin HC, Byun YR. 2001. Conjugation of low-molecular-weight heparin and deoxycholic acid for the development of a new oral anticoagulant agent. Circulation 104: 3116-3120.
14. Matern S, Gerok W. 1979. Pathophysiology of the enterohepatic circulation of bile acids. Rev Physiol Biochem Pharmacol 85: 125-204.
15. Meadows RP, Nikonowicz EP, Jones CR, Bastian JW, Gorenstein DV. 1991. Two-dimensional NMR and structure determination of salmon calcitonin in methanol. Biochemistry 30:1247-1254.
16. Rodan GA, Martin TJ. 2000. Therapeutic approaches to bone diseases. Science 289:1508-1514.
17. Sakuma S, Suzuki N, Sudo R, Hiwatari K, Kishida A, Akashi M. 2002. Optimized chemical structure of nanoparticles as carriers for oral delivery of salmon calcitonin. Intl J Pharm 239:185-195.
18. Sonnichsen FD, Van Eyk JE, Hodges RS, Sykes BD. 1992. Effect of trifluoroethanol on protein secondary structure: an NMR and CD study using a synthetic actin peptide. Biochemistry 31:8790-8798.
19. Torres-Lugo M, Peppas NA. 1999. Molecular design and in vitro studies of novel pH-sensitive hydrogels for the oral delivery of calcitonin. Macromolecules 32:6646-6651.
20. Wearley LL. 2001. Recent progress in protein and peptide delivery by noninvasive routes. Grit Rev Ther Drug Carrier Syst 8:331-394.
21. Zhu XX, Nichifor M. 2002. Polymeric materials containing bile acids. Acc Chem Res 35:539-546.